Coherus Oncology, Inc 10-K for FY2023
Coherus Oncology, Inc. (CHRS)
10-K
2024-03-15
For: 2023-12-31
View Original
Added on
April 09, 2026
About this 10-K
Coherus Oncology, Inc filed this 10-K on March 15, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $257.24M
- up 21.9% from $211.04M a year earlier
- Net loss
- $237.89M
- compared with a net loss of $291.75M a year earlier
- Diluted EPS
- -$2.53
- compared with -$3.76 a year earlier